Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Gross Profit readings, the most recent being $18.6 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 61.08% to $18.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $137.7 million, a 34.17% decrease, with the full-year FY2025 number at $141.3 million, down 37.78% from a year prior.
  • Gross Profit hit $18.6 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $30.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $79.1 million in Q3 2024 to a low of -$116.4 million in Q1 2023.
  • Median Gross Profit over the past 5 years was $27.1 million (2022), compared with a mean of $4.7 million.
  • The widest YoY moves for Gross Profit: up 6219.09% in 2023, down 488.38% in 2023.
  • Ginkgo Bioworks Holdings' Gross Profit stood at -$32.3 million in 2021, then surged by 101.7% to $550000.0 in 2022, then soared by 6219.09% to $34.8 million in 2023, then skyrocketed by 37.47% to $47.8 million in 2024, then tumbled by 61.08% to $18.6 million in 2025.
  • The last three reported values for Gross Profit were $18.6 million (Q4 2025), $30.7 million (Q3 2025), and $44.2 million (Q2 2025) per Business Quant data.